Front & Back Matter.
- Published in:
- Chemotherapy (0009-3157), 2023, v. 68, n. 2, p. 1, doi. 10.1159/000531417
- Publication type:
- Article
Works matching IS 00093157 AND DT 2023 AND VI 68 AND IP 2
Results: 8
1
2
Evaluation of a Novel Combination Therapy, Based on Trifluridine/Tipiracil and Fruquintinib, against Colorectal Cancer.
- Published in:
- Chemotherapy (0009-3157), 2023, v. 68, n. 2, p. 102, doi. 10.1159/000528867
- By:
- Publication type:
- Article
3
Drug Interactions Causing Warfarin Overdose in a Patient with Pancreatic Cancer: A Case Report.
- Published in:
- Chemotherapy (0009-3157), 2023, v. 68, n. 2, p. 111, doi. 10.1159/000528063
- By:
- Publication type:
- Article
4
Ibrutinib and Bruton's Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: Focus on Atrial Fibrillation and Ventricular Tachyarrhythmias/Sudden Cardiac Death.
- Published in:
- Chemotherapy (0009-3157), 2023, v. 68, n. 2, p. 61, doi. 10.1159/000528019
- By:
- Publication type:
- Article
5
Targeted Therapy of Non-Small Cell Lung Cancer and Liver Cancer: Functional Nanocarriers for the Delivery of Cisplatin and Tissue Factor Pathway Inhibitor-2.
- Published in:
- Chemotherapy (0009-3157), 2023, v. 68, n. 2, p. 73, doi. 10.1159/000527536
- By:
- Publication type:
- Article
6
Clinical Analysis of Extrapulmonary Neuroendocrine Carcinoma: A Retrospective and Single Institution Experience.
- Published in:
- Chemotherapy (0009-3157), 2023, v. 68, n. 2, p. 87, doi. 10.1159/000527377
- By:
- Publication type:
- Article
7
Initiating Treatment with Low Fluorouracil Dose and Titrating According to Blood Levels in Patients Treated with a 46-Hour Continuous Infusion.
- Published in:
- Chemotherapy (0009-3157), 2023, v. 68, n. 2, p. 95, doi. 10.1159/000526827
- By:
- Publication type:
- Article
8
Safety Signal between Azacitidine and Pericarditis.
- Published in:
- Chemotherapy (0009-3157), 2023, v. 68, n. 2, p. 115, doi. 10.1159/000526610
- By:
- Publication type:
- Article